Cargando…
A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalin
BACKGROUND: Pregabalin is a therapeutic drug for neuropathic pain that is associated with somnolence and dizziness. These adverse events are often experienced shortly after initiating pregabalin, and may lead to treatment discontinuation. The purpose of this study was to explore factors that influen...
Autores principales: | Kato, Hiroshi, Miyazaki, Masayuki, Takeuchi, Mio, Tsukuura, Hiroaki, Sugishita, Mihoko, Noda, Yukihiro, Yamada, Kiyofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728751/ https://www.ncbi.nlm.nih.gov/pubmed/26819733 http://dx.doi.org/10.1186/s40780-015-0022-7 |
Ejemplares similares
-
Erratum to: A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalin
por: Kato, Hiroshi, et al.
Publicado: (2016) -
Opioid analgesics increase incidence of somnolence and dizziness as adverse effects of pregabalin: a retrospective study
por: Ohishi, Akihiro, et al.
Publicado: (2015) -
Somnolence and Dizziness During Mirogabalin Treatment in Patients With Neuropathic Pain Related to Lumbar Disease Who Switched From Pregabalin: A Retrospective Study
por: Akazawa, Tsutomu, et al.
Publicado: (2021) -
On the Use of Chloral Hydrate in Lethargic Somnolency
por: Burnett, J. C.
Publicado: (1883) -
Somnolence Preceded the Development of a Subthalamic Lesion in Neuromyelitis Optica Spectrum Disorder
por: Daida, Kensuke, et al.
Publicado: (2019)